Washington Post (12.10.06) - Monday, December 18, 2006
Amy Joyce

"[HIV-positive] people are living longer and working longer, and that just puts more of a spotlight on some of the workplace challenges that need to be addressed in these policies," said Peter J. Petesch, managing partner with the Ford & Harrison law firm and a board member for CDC's Business Responds to AIDS program.

Baltimore-based Catholic Relief Services operates in 99 countries, and part of its mission is providing services to people with HIV/AIDS. Yet for its own HIV-positive employees, CRS had a minimal, outdated policy dating back to 2001.

CRS eventually instituted a new HIV policy that was one year in the making. Now in place for 10 months, the CRS program includes HIV/AIDS education training for all employees, information for managers and employees about what CRS can do for people with HIV, and 100 percent coverage for all HIV treatment and testing for its employees. The agency hopes to encourage its 5,000 employees to seek testing and, if necessary, treatment.

"We started to recognize as an agency that the same stigma and access to treatment issues are actually affecting our own staff. Here we were saving people in the community but losing our own staff to HIV," said Jennifer Munthali, an HIV-positive CRS staffer who helped write the new policy.

Other organizations are inquiring as to how CRS created its policy and what challenges it faced. Complete treatment coverage has cost less than 20 percent of CRS's overall HIV workplace budget, said Munthali. "That helps other agencies learn this is something affordable and the cost benefit is a healthier staff that is well informed and able to contribute to the work."

For more information, visit www.hivatwork.com
061218
AD062442

Copyright © 2006 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .